Integrated Nuclear Medicine Research and Training Projects of Excellence

Post Date

January 20th 2012

Application Due Date

March 28th 2012

Funding Opportunity Number

DE-FOA-0000646

CFDA Number(s)

81.049

Funding Instrument Type(s)

Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

10

Eligibility Categories

Unrestricted

All types of entities are eligible to apply, except other Federal agencies, Federally Funded Research and Development Center (FFRDC) Contractors, and nonprofit organizations described in section 501(c)(4) of the Internal Revenue Code of 1986 that engaged in lobbying activities after December 31, 1995. Synergistic collaborations with researchers in Federal Laboratories and Federally Funded Research and Development Centers (FFRDCs), including the DOE National Laboratories are permitted. Collaborations should be limited to filling critical voids in expertise and can represent no more than 50 percent of the total budget.

Funding

• Estimated Total Funding:

  $10000000

• Award Range:

  $0 - $2000000

Grant Description

The U.S. Department of Energy's Office of Science, Office of Biological and Environmental Research (BER) hereby announces its interest in receiving applications for potential funding of Integrated Nuclear Medicine Research and Training Projects of Excellence to serve three important goals: 1. Research and development of new and highly innovative radiotracer methods and radiotracers as potential imaging agents for nuclear medicine research and application to advance the understanding of normal human physiology and gene expression, diagnosis and management of disease, in drug research and development, and in translational science; 2. Integrated involvement of postdoctoral fellows (Ph.D. radiochemists) and M.D., or M.D.-Ph.D fellows with specialties in Nuclear Medicine with applications to human health in developing and deploying new radiotracers for nuclear medicine imaging and potential clinical use in humans for disease-specific applications; and 3. Enhancement of training opportunities to ensure the future availability of human resources for highly specialized fields of radiotracer development chemistry and clinical nuclear medicine research and allied disciplines.   Applicants must have access to existing advanced facilities and an interdisciplinary collaborative team of radiochemists, synthetic chemists, biochemists and other expertise including physician scientists specialized in human disease- or disorder-specific nuclear medicine imaging, with the ability to support a robust research training environment. Institutional settings with easy access to nuclear medicine imaging specialties such as positron emission tomography (PET) and SPECT (single photon emission computed tomography) are required and should offer broad ranging research collaborations from research and development of radiotracers to translation for potential clinical use in humans. For further details, refer to the provided supplementary information.

Contact Information

• Agency

  Department of Energy - Office of Science

• Office:

  Office of Science

• Agency Contact:

  Kimberlie J. Laing, Grant Analyst, 301-903-3026
  kim.laing@science.doe.gov
  Prem C. Srivastava, Program Manager, 301-903-4071
  prem.srivastava@science.doe.gov
  

• Agency Mailing Address:

  kim.laing@science.doe.gov

• Agency Email Address:

  kim.laing@science.doe.gov

• More Information:

  FedConnect